title: Use of antimuscarinics in the elderly.
abstract: Overactive bladder (OAB) is a common, costly, and treatable condition in older persons. There is a wide array of available antimuscarinics for the treatment of these conditions; however, their side effect profile and the limited number of studies that evaluate their effect in the elderly curb their use. This review article focuses on OAB and its treatment, with special attention to the use of antimuscarinics in the elderly.
authors.affiliation: Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. bpatel@wfubmc.edu
authors.forename: Bhavin
authors.initials: B
authors.lastname: Patel
authors.forename: Tamara
authors.initials: T
authors.lastname: Bavendam
authors.forename: Gopal
authors.initials: G
authors.lastname: Badlani
mesh_terms: D000368:Aged; D001572:Benzofurans / Q000627:therapeutic use; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D001572:Benzofurans; D018727:Muscarinic Antagonists; D011759:Pyrrolidines; C101207:darifenacin